Docmode Health Technologies (NSE:DHTL) Current Deferred Revenue: ₹0.0 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:DHTL Docmode Health Technologies Ltd NSE:DHTL
14 GF Score
Price ₹35.65
View Full Analysis

What is Docmode Health Technologies Current Deferred Revenue?

Docmode Health Technologies NSE:DHTL -4.93% 14 Current Deferred Revenue is ₹0.0 Mil as of Mar. 2025. GuruFocus rates NSE:DHTL with a GF Score™ of 14/100.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Docmode Health Technologies's current deferred revenue for the quarter that ended in Mar. 2025 was ₹0.0 Mil.

Docmode Health Technologies Current Deferred Revenue Related Terms

Docmode Health Technologies Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Docmode Health Technologies's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Docmode Health Technologies Current Deferred Revenue Chart

Docmode Health Technologies Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Current Deferred Revenue
0.00 0.00 0.00 0.00 0.00

Docmode Health Technologies Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25
Current Deferred Revenue Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
NSE:DHTL
14GF Score
Docmode Health Technologies Ltd NSE:DHTL
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of ₹0.0 Mil mean?
Docmode Health Technologies (NSE:DHTL) has a Current Deferred Revenue of ₹0.0 Mil as of Mar. 2025. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Docmode Health Technologies and its competitors.
Is Docmode Health Technologies' Current Deferred Revenue too high?
Docmode Health Technologies' current Current Deferred Revenue is ₹0.0 Mil. Overall, Docmode Health Technologies has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Docmode Health Technologies' Current Deferred Revenue compare to VEEV and BTSG?
Docmode Health Technologies' Current Deferred Revenue of ₹0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Docmode Health Technologies and its competitors. Docmode Health Technologies's current Current Deferred Revenue is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Docmode Health Technologies stock overvalued right now?
Docmode Health Technologies (NSE:DHTL) has a current Current Deferred Revenue of ₹0.0 Mil. The current Current Deferred Revenue is ₹0.0 Mil. Docmode Health Technologies' overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Docmode Health Technologies (NSE:DHTL), the current Current Deferred Revenue is ₹0.0 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Docmode Health Technologies Business Description

Address Chincholi Bunder Road, 201, Kalpataru Plaza, Rambaug Off, Nadiyawala Colony 2, Malad, Mumbai, MH, IND, 400064
Docmode Health Technologies Ltd is engaged in the business of providing comprehensive & interactive learning programs for healthcare professionals through e-Learning measures and providing online CME (continuous medical education) Certification Courses and designing & conducting surveys, quizzes, questionnaires, etc. for collecting data insights related to the healthcare industry Its business segment is engaged in providing vocational training, DocMode is a platform that provides authoritative, comprehensive, and interactive learning programs for Health Professionals - Doctors, Nurses, Allied and Medical Students - across the world. The company has a new segments namely publishing of Medical books, trading of medical books and journals, conducting customised and inhouse events.
14GF Score

Get the complete analysis for NSE:DHTL

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹35.65
Price